Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1990 | 12-1989 | |
| Cash Flows From Operating Activities | ||
| Net Income | -4,330 | -1,894 |
| Depreciation Amortization | 1,277 | 94 |
| Other Working Capital | -81 | 676 |
| Other Operating Activity | 147 | 0 |
| Operating Cash Flow | $-2,987 | $-1,125 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -1,094 | -963 |
| Other Investing Activity | 788 | -987 |
| Investing Cash Flow | $-306 | $-1,950 |
| Cash Flows From Financing Activities | ||
| Other Financing Activity | 5,004 | 5,796 |
| Financing Cash Flow | $5,004 | $5,796 |
| Beginning Cash Position | 2,721 | N/A |
| End Cash Position | 4,433 | 2,721 |
| Net Cash Flow | $1,712 | $2,721 |
| Free Cash Flow | ||
| Operating Cash Flow | -2,987 | -1,125 |
| Free Cash Flow | -2,987 | -1,125 |